# Efficacy and Safety of the ACC017-Based Antiretroviral Regimen in Treatment-Experienced Adults With HIV-1 Harboring Non-Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations

> clinical trial · VERIFIED · 2026-07-17

Status: ACTIVE_NOT_RECRUITING · Sponsor: Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Condition: Infection, Human Immunodeficiency Virus

- Company: Jiangsu Aidea Pharmaceutical Group Co., Ltd.
- Sector: Infection, Human Immunodeficiency Virus
- Primary source: https://clinicaltrials.gov/study/NCT07711210

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.